At TTS Pharma, we are committed to advancing the medicinal cannabis and wellness industries through innovation, integrity, and scientific excellence. With a strong foundation in research, regulatory compliance, and product development, we deliver high-quality cannabinoid-based solutions that meet the evolving needs of healthcare professionals, patients, and consumers. Our expertise spans the entire supply chain, from cultivation and extraction to formulation and distribution, ensuring the highest standards of safety, efficacy, and consistency. We work closely with regulators, medical professionals, and industry leaders to drive progress in cannabinoid-based healthcare while adhering to the strictest compliance frameworks. With a team focused on quality, transparency, and sustainability, we are dedicated to shaping the future of medicinal cannabis and wellness solutions. Whether through our own product lines or strategic partnerships, we empower businesses and healthcare providers with trusted, high-purity cannabinoid products tailored to market demands. Join us on our mission to set new benchmarks in medicinal cannabis and wellness innovation.
| Website | https://www.ttspharma.com/ |
| Revenue | $192000 |
| Employees | 2 (2 on RocketReach) |
| Founded | 2012 |
| Phone | +44 7875 210959 |
| Technologies |
JavaScript
,
HTML
,
PHP
+15 more
(view full list)
|
| Industry | Manufacturing, Manufacturing General, Biopharma, Medical Supplies, Biotechnology, Drug Delivery, Health Care, Science and Engineering, Pharmaceutical |
| Keywords | Cannabinoid Products, Cbd Products, Ethical Cannabis, Cannabis Market, Cannabis Production, High Quality Cannabis, Pharmaceutical Grade, Pharmaceutical Cannabis, Cannabis Cultivation, Medical Cannabis, Legal Cannabis, Cannabis Extracts, Vertically Integrated, Cannabinoid Research, Cannabis Legislation, Cannabis Regulations |
| Competitors | Teva Pharmaceuticals, Mylan Belgium, Amgen, AbbVie, Bristol Myers Squibb, Novartis, Lilly India, GSK, Pfizer, Roche +41 more (view full list) |
| SIC | SIC Code 283 Companies, SIC Code 28 Companies |
| NAICS | NAICS Code 32541 Companies, NAICS Code 325 Companies, NAICS Code 32 Companies, NAICS Code 3254 Companies |
Looking for a particular TTS Pharma employee's phone or email?
The TTS Pharma annual revenue was $192000 in 2026.
Mark Tucker is the CEO of TTS Pharma.
2 people are employed at TTS Pharma.
The NAICS codes for TTS Pharma are [32541, 325, 32, 3254].
The SIC codes for TTS Pharma are [283, 28].